Aptevo Therapeutics Inc
NASDAQ:APVO
Decide at what price you'd be comfortable buying and we'll help you stay ready.
|
Aptevo Therapeutics Inc
NASDAQ:APVO
|
US |
|
S
|
Serko Ltd
ASX:SKO
|
NZ |
|
C
|
Cadence Design Systems Inc
LSE:0HS2
|
US |
|
A
|
Aflac Inc
XHAN:AFL
|
US |
|
Gaztransport et Technigaz SA
PAR:GTT
|
FR |
|
A
|
Asics Corp
OTC:ASCCF
|
JP |
|
Eros Media World PLC
OTC:EMWPF
|
AE |
|
V
|
Valeo SE
F:VSA
|
FR |
|
L
|
Lanvin Group Holdings Ltd
NYSE:LANV
|
CN |
|
A
|
Assicurazioni Generali SpA
SWB:ASG
|
IT |
|
Quaker Chemical Corp
NYSE:KWR
|
US |
|
Ajinomoto Co Inc
F:AJI
|
JP |
|
G
|
Global Payments Inc
SWB:GLO
|
US |
|
Secuoya Grupo de Comunicacion SA
MAD:SEC
|
ES |
|
A
|
Amba Enterprises Ltd
BSE:539196
|
IN |
|
Majestic Corporation PLC
OTC:MCJCF
|
UK |
|
D
|
Digital Realty Trust Inc
SWB:FQI
|
US |
|
F
|
Freeport-McMoRan Inc
F:FPMB
|
US |
|
H
|
Home Product Center PCL
SET:HMPRO
|
TH |
Bankruptcy Probability
Aptevo Therapeutics Inc's probability of bankruptcy is Hidden . The solvency score is Hidden .
We take all the information about a company's solvency, such as how easily it can pay interest on outstanding debt, how much cash it has, the amount of debt, and more, and use it to estimate the probability of bankruptcy.
Solvency Ratios
Solvency Ratios Comparison
Aptevo Therapeutics Inc Competitors
| Country | Company | Market Cap | D/E | D/A |
Interest Coverage |
Altman Z-Score |
Quick Ratio |
Current Ratio |
Cash Ratio |
||
|---|---|---|---|---|---|---|---|---|---|---|---|
| US |
|
Aptevo Therapeutics Inc
NASDAQ:APVO
|
2.3m USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
AbbVie Inc
NYSE:ABBV
|
468.5B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Amgen Inc
NASDAQ:AMGN
|
219.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Gilead Sciences, Inc
NASDAQ:GILD
|
185.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Vertex Pharmaceuticals Inc
NASDAQ:VRTX
|
132.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Regeneron Pharmaceuticals Inc
NASDAQ:REGN
|
82.3B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Moderna Inc
NASDAQ:MRNA
|
77.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| NL |
|
argenx SE
XBRU:ARGX
|
52.9B EUR |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| AU |
|
CSL Ltd
ASX:CSL
|
84.7B AUD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Natera Inc
NASDAQ:NTRA
|
58.7B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
|
| US |
|
Revolution Medicines Inc
NASDAQ:RVMD
|
42.8B USD |
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Loading...
|
Aptevo Therapeutics Inc's probability of bankruptcy is Hidden .
The probability of bankruptcy is estimated using credit risk models that assess financial health, debt levels, interest coverage, and other solvency indicators.
As of the latest report, Aptevo Therapeutics Inc has no debt.
You can find a full breakdown on its Balance Sheet.